AGIO
Price
$40.50
Change
+$0.57 (+1.43%)
Updated
Oct 3 closing price
Capitalization
2.35B
24 days until earnings call
NVCT
Price
$6.00
Change
-$0.06 (-0.99%)
Updated
Oct 3 closing price
Capitalization
152.87M
36 days until earnings call
Interact to see
Advertisement

AGIO vs NVCT

Header iconAGIO vs NVCT Comparison
Open Charts AGIO vs NVCTBanner chart's image
Agios Pharmaceuticals
Price$40.50
Change+$0.57 (+1.43%)
Volume$525.44K
Capitalization2.35B
Nuvectis Pharma
Price$6.00
Change-$0.06 (-0.99%)
Volume$42.33K
Capitalization152.87M
AGIO vs NVCT Comparison Chart in %
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGIO vs. NVCT commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a StrongBuy and NVCT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (AGIO: $40.50 vs. NVCT: $6.01)
Brand notoriety: AGIO and NVCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 63% vs. NVCT: 42%
Market capitalization -- AGIO: $2.35B vs. NVCT: $152.87M
AGIO [@Biotechnology] is valued at $2.35B. NVCT’s [@Biotechnology] market capitalization is $152.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 1 FA rating(s) are green whileNVCT’s FA Score has 0 green FA rating(s).

  • AGIO’s FA Score: 1 green, 4 red.
  • NVCT’s FA Score: 0 green, 5 red.
According to our system of comparison, AGIO is a better buy in the long-term than NVCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 6 TA indicator(s) are bullish while NVCT’s TA Score has 3 bullish TA indicator(s).

  • AGIO’s TA Score: 6 bullish, 3 bearish.
  • NVCT’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, AGIO is a better buy in the short-term than NVCT.

Price Growth

AGIO (@Biotechnology) experienced а +4.03% price change this week, while NVCT (@Biotechnology) price change was -1.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

AGIO is expected to report earnings on Oct 30, 2025.

NVCT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGIO($2.35B) has a higher market cap than NVCT($153M). AGIO YTD gains are higher at: 23.250 vs. NVCT (10.998). NVCT has higher annual earnings (EBITDA): -22.97M vs. AGIO (-456.28M). AGIO has more cash in the bank: 939M vs. NVCT (26.8M). AGIO has higher revenues than NVCT: AGIO (40.9M) vs NVCT (0).
AGIONVCTAGIO / NVCT
Capitalization2.35B153M1,538%
EBITDA-456.28M-22.97M1,986%
Gain YTD23.25010.998211%
P/E Ratio3.54N/A-
Revenue40.9M0-
Total Cash939M26.8M3,504%
Total Debt48.8MN/A-
FUNDAMENTALS RATINGS
AGIO: Fundamental Ratings
AGIO
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
17
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
59
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGIONVCT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
89%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 5 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
75%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
69%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TROZX23.110.18
+0.78%
T. Rowe Price International Value Eq Z
GREUX11.990.05
+0.42%
Goldman Sachs Real Estate Securities R6
ISVGX22.130.05
+0.23%
Voya Growth and Income Port S
IVOSX20.040.04
+0.20%
Macquarie Mid Cap Income Opps R6
QCBGX23.06-0.02
-0.09%
Federated Hermes MDT Balanced C

AGIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGIO has been loosely correlated with LGND. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if AGIO jumps, then LGND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGIO
1D Price
Change %
AGIO100%
+1.43%
LGND - AGIO
50%
Loosely correlated
+0.48%
VRDN - AGIO
46%
Loosely correlated
+2.03%
CRNX - AGIO
46%
Loosely correlated
-1.57%
AXON - AGIO
45%
Loosely correlated
-0.70%
ZYME - AGIO
45%
Loosely correlated
+0.24%
More

NVCT and

Correlation & Price change

A.I.dvisor tells us that NVCT and PDSB have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVCT and PDSB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
-1.07%
PDSB - NVCT
32%
Poorly correlated
N/A
ADMA - NVCT
30%
Poorly correlated
+0.89%
SGMT - NVCT
28%
Poorly correlated
+1.82%
ZLAB - NVCT
26%
Poorly correlated
-0.30%
AGIO - NVCT
26%
Poorly correlated
+1.43%
More